MENU
Home
News
News
CME
CME
Journals
Journals
Account Anonymous User
Account Known User
All Specialties
All Specialties
Aesthetics
Allergy/Asthma
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Women's Health & OB/GYN
Hematology/Oncology
All Subspecialties
All Subspecialties
Bone Marrow Transplantation
Breast Cancer
Cancer Prevention
Cell Therapy
Gastrointestinal Cancer
Genitourinary Cancer
Geriatric Oncology
Gynecologic Cancer
Head/Neck Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Melanoma/Skin Cancer
Myeloma
Myeloproliferative Neoplasms
Neuro-Oncology
Palliative Care
Pediatric Oncology
Practice Management
Prostate Cancer
Sarcoma
Survivorship
More
Resources
Meeting News
Opinion
Meeting Calendar
My Account
Log Out
Log In
News
Close Searchbar
Search
News
CME
Journals
Account
Log In
Log In
Log Out
Log Out
All Specialties
All Specialties
Aesthetics
Allergy/Asthma
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Women's Health & OB/GYN
All Subspecialties
All Subspecialties
Bone Marrow Transplantation
Breast Cancer
Cancer Prevention
Cell Therapy
Gastrointestinal Cancer
Genitourinary Cancer
Geriatric Oncology
Gynecologic Cancer
Head/Neck Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Melanoma/Skin Cancer
Myeloma
Myeloproliferative Neoplasms
Neuro-Oncology
Palliative Care
Pediatric Oncology
Practice Management
Prostate Cancer
Sarcoma
Survivorship
Resources
Meeting News
Expand Dropdown Menu
Opinion
Meeting Calendar
Search
Healio
News
Hematology/Oncology
Current Issues
Cell Therapy Next Current Issue
Related Resources
About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Peer Perspective Board
Mission Statement
Subscribe
Year
2022
2021
2020
2019
2018
Issue
February
April
View Issue
The following articles appeared in the print edition of
Cell Therapy Next
.
Table of Contents
COVID-19 prevention must extend beyond vaccines for patients receiving cell therapies
Drew Amorosi
FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma
Drew Amorosi
FDA places clinical hold on Legend Biotech’s CAR-T for T-cell lymphoma
FDA approves Yescarta as second-line therapy for large B-cell lymphoma
Drew Amorosi
Investigational therapy for B-cell malignancies offers three targets in one CAR T cell
Drew Amorosi; Reshmi Parameswaran, MS, PhD
Lack of awareness, limited sites hinder CAR-T trials for younger patients with cancer
Drew Amorosi
From referral to infusion: Accelerating the CAR-T process
Drew Amorosi
CAR T-cell therapy trial paused after two patient deaths
Early intrathecal therapy shows promise for managing neurotoxicity related to CAR-T
Drew Amorosi
Personalized cell therapy shows promise in metastatic breast cancer
Drew Amorosi
Researchers develop test to predict durable remissions after CAR-T for lymphoma
Drew Amorosi
Axi-cel CAR-T significantly improves EFS among older patients with non-Hodgkin lymphoma
Drew Amorosi
Next breakthrough for CAR T cells may come in acute myeloid leukemia
Drew Amorosi
Nonviral CAR-T is ‘remarkably safe’ and clinically active in B-cell ALL
Drew Amorosi
Scoring system predicts infection risk, treatment outcomes after CAR-T
Drew Amorosi
Related Resources
About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Peer Perspective Board
Mission Statement
Subscribe
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact
ITSupport@wyanokegroup.com
for assistance.